Omalirel (Omalizumab) 150mg

Omalirel (omalizumab) 150mg injection is a prescription biologic used for allergic asthma and chronic urticaria symptom control. This 1s single-use vial supports targeted IgE management with stable storage at 2–8°C. Reliable allergy relief with a proven safety profile for long-term use.

Strength

150mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Reliance Life Sciences Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Omalizumab 150mg is primarily used to reduce allergic asthma symptoms in patients with moderate to severe persistent asthma triggered by allergens. It is also indicated for chronic spontaneous urticaria in adults and adolescents whose hives remain uncontrolled despite antihistamine therapy. This medication helps decrease the frequency and severity of allergy-related reactions by targeting immunoglobulin E.

Side Effects

Omalizumab 150mg works by binding to IgE antibodies, reducing their ability to trigger allergic responses. Users often report fewer asthma flare-ups and less itching or hives over time. Symptom improvement may take several weeks of consistent use. Individual responses vary based on allergy severity and treatment duration.

Precautions & Warnings

Keep Omalirel 150mg refrigerated between 2–8°C and protect from light until use. Do not freeze or shake vigorously. Before administration, allow the vial to reach room temperature for 15–20 minutes. Discard any unused portion after single use. Always follow healthcare provider instructions for proper injection technique and monitoring.

Avoid Interactions

Omalizumab 150mg has a low potential for drug interactions due to its targeted mechanism. No significant interactions with vaccines, antihistamines, or inhaled corticosteroids have been reported. However, concurrent use of other biologics or immunosuppressants should be discussed with a doctor. Alcohol and certain foods do not affect its efficacy.

References

Frequently Asked Questions

Omalizumab 150mg is used to treat moderate to severe allergic asthma and chronic spontaneous urticaria in patients who do not respond adequately to standard therapies.

Symptom improvement may take several weeks of regular use, with full effects often seen after 12–16 weeks of treatment.

Omalizumab 150mg is available by prescription only and may be purchased from licensed pharmacies or authorized online medical suppliers with a valid prescription.

Omalizumab is designed for long-term use under medical supervision, with safety monitored through regular check-ups and lab tests.

Contact your healthcare provider for guidance; do not take a double dose to make up for a missed injection.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.